Early Clinical Results and Post-Commercialization Use of the BEAR Implant скачать в хорошем качестве

Early Clinical Results and Post-Commercialization Use of the BEAR Implant

Early Clinical Results and Post-Commercialization Use of the BEAR Implant. Topics Discussed: • Early clinical results of the BEAR III study • 1st interim analysis of the Bridge Registry • Real world use of the BEAR Implant highlighting technique modifications Speakers: • Jacqueline M. Brady, MD Oregon Health & Science University - Portland, OR • Sabrina Strickland, MD Hospital for Special Surgery - New York, NY • Jocelyn Wittstein, MD Duke - Raleigh, NC • Keith Baumgarten, MD Orthopedic Institute - Sioux Falls, SD For more information on the BEAR Implant, visit https://miachortho.com/healthcare-pro... The BEAR Implant was cleared by the U.S. Food & Drug Administration through the De Novo Pathway. It is indicated for skeletally mature patients at least 14 years of age with a complete rupture of the ACL, as confirmed by MRI. Patients must have an ACL stump attached to the tibia to construct the repair. For full product and risk information, including indications, contraindications, warnings and potential adverse effects, see the Instructions for Use at https://miachortho.com/IFU/ ©2024 Miach Orthopaedics. All rights reserved. ML-1226 Rev A 10/2024